Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03888820 · ClinicalTrials.gov registry record · Phase 4

Biofreeze® vs. a Placebo on Chronic Low Back Pain Walking Gait Characteristics and Pain

A Phase 4 study of Chronic Low Back Pain, sponsored by Sport and Spine Rehab Clinical Research Foundation.

Active
Registry status
Phase 4
Development phase
20
Enrollment target
1
Study location

NCT03888820 is a Phase 4 study of Chronic Low Back Pain that is active but no longer recruiting, run by Sport and Spine Rehab Clinical Research Foundation. The registered enrollment target is 20 participants, below the 592-participant average among 71 other Chronic Low Back Pain trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03888820, a Phase 4 study of Chronic Low Back Pain, is active but no longer recruiting, sponsored by Sport and Spine Rehab Clinical Research Foundation.

ACTIVE NOT RECRUITING
Registry status
Phase 4
Development phase
20 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to determine the effect of Biofreeze® versus a placebo on walking gait characteristics and pain during walking in individuals with cLBP.

Conditions Studied

Interventions

  • DRUG Placebo
  • DRUG Biofreeze

Study Locations (1)

Maryland

  • Sport and Spine Rehab - Rockville

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2018-03-01
Est. Completion 2019-04-30
Phase Phase 4

What the Registry Record Tells You About NCT03888820

The ClinicalTrials.gov registry entry for NCT03888820 describes a study currently listed as active not recruiting, categorized as Phase 4. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 592-participant average among 71 other Chronic Low Back Pain trials with a reported enrollment target (97% lower). The listed sponsor is Sport and Spine Rehab Clinical Research Foundation, which has 16 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Chronic Low Back Pain appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT03888820 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.

Frequently Asked Questions

What is clinical trial NCT03888820 about?

NCT03888820 is a clinical study titled "Biofreeze® vs. a Placebo on Chronic Low Back Pain Walking Gait Characteristics and Pain". The purpose of this study is to determine the effect of Biofreeze® versus a placebo on walking gait characteristics and pain during walking in individuals with cLBP.

What is the current status of trial NCT03888820?

This trial is currently active not recruiting. It is a Phase 4 study. The enrollment target is 20 participants. The study started on 2018-03-01. Estimated completion is 2019-04-30.

What conditions does trial NCT03888820 study?

This clinical trial studies the following conditions: Chronic Low Back Pain.

What interventions are being tested in trial NCT03888820?

The interventions under investigation include: Placebo (DRUG), Biofreeze (DRUG).

Who is sponsoring clinical trial NCT03888820?

This trial is sponsored by Sport and Spine Rehab Clinical Research Foundation, which has 16 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03888820 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Chronic Low Back Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.